Covered recipient · General Payments record
OMAR ALHALABI
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$7,788.99
- Reported across 42 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $617.35 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $223.06 | 3 |
| Acerta Pharma LLC | $135.00 | 1 |
| Genentech USA, Inc. | $46.49 | 1 |
| Merck Sharp & Dohme Corporation | $44.21 | 2 |
| Gilead Sciences, Inc. | $42.84 | 2 |
| Exelixis Inc. | $40.70 | 2 |
| EISAI INC. | $32.92 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $28.41 | 1 |
| ABBVIE INC. | $23.72 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.72 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103202405 | CMS |
| AstraZeneca Pharmaceuticals LP | $135.00 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105739097 | CMS |
| Eisai Inc. | $32.92 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110771035 | CMS |
| Exelixis Inc. | $18.25 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138563456 | CMS |
| Exelixis Inc. | $22.45 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138563458 | CMS |
| Genentech USA, Inc. | $46.49 | 06/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133083774 | CMS |
| Gilead Sciences, Inc. | $19.42 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133802978 | CMS |
| Gilead Sciences, Inc. | $23.42 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133802980 | CMS |
| Janssen Biotech, Inc. | $34.77 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078727055 | CMS |
| Janssen Biotech, Inc. | $154.87 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078720149 | CMS |
| Janssen Biotech, Inc. | $33.42 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078723457 | CMS |
| Merck Sharp & Dohme LLC | $19.32 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141596500 | CMS |
| Merck Sharp & Dohme LLC | $24.89 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141596498 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $28.41 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152188963 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.